Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3‐arm, pilot trial
Journal of Cosmetic Dermatology · 2024-02 · 23 (2) · 502-509
DOI: 10.1111/jocd.15953 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 05.10.2023. Verfasst von Alfredo Rossi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Dermatologic Clinic Policlinico Umberto 1, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Minoxidil, Finasteride. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Topical minoxidil (MNX) 2%–5% and oral finasteride (F) 1 mg/day are the only two pharmacological treatments authorized for androgenetic alopecia (AGA). Recently, a 2.2 mg/mL topical formulation of F was developed to minimize the systemic adverse effects associated with the oral formula. MNX and F act through different mechanisms; therefore, their association could improve clinical efficacy. To evaluate the efficacy of the association of 5% MNX and 0.25% topical F compared to their use in monotherapy, a 6‐month, prospective, randomized, assessor‐blinded trial was conducted. Patients and Methods Forty‐two males, mean age 24 ± 3 years, with AGA (I–VII of Norwood‐Hamilton Grading Scale), treatment naive or free from any therapy for at least 6 months, were enrolled and randomly assigned to three arm treatment groups (2:1:1): group A ( n = 19, the subjects applied 5% MNX in the morning and F spray in the evening), group B ( n = 12, the subjects applied F spray in the evening), and group C ( n = 11, the subjects applied 5% MNX twice daily). The efficacy of treatments was evaluated at baseline and after 3 and 6 months using a global photography score (GPAS; from −3 to +3) and trichoscopy evaluation and assessed by an investigator unaware of treatment allocation. At baseline and after treatments, the serum levels of follicle‐stimulating hormone (FSH), luteinizing hormone (LH), dehydroepiandrosterone sulfate (DHEA‐S), and testosterone were also evaluated.
Results
All treatments resulted in an increase in hair density compared to baseline. However, this improvement was significant only for group A (MNX + F), both at three (+56 density/cm 2 , p < 0.05) and six (+81 density/cm 2 , p < 0.001) months. The mean change from baseline in hair density was higher for group A compared to other groups and statistically different compared to group B (F) ( p < 0.01), both after 3 and 6 months. Group A showed a global photographic assessment score (GPAS) significantly higher compared to group B ( p < 0.001) and group C ( p < 0.05) both at 3 and 6 months (2.0 ± 0.7 vs. 0.6 ± 0.8 and 1.3 ± 0.6; respectively). A significantly greater percentage of subjects in Group A achieved a GPAS score of ≥2 in comparison with Groups B and C both after 3 and 6 months (79% vs. 8% and 41%, respectively). No significant differences were observed in mean hair diameter and hormonal levels between the three groups. Good tolerability was observed in all treated groups.
Conclusion
The association of 5% MNX lotion and 0.25% F in spray formulation in patients with AGA showed a significantly higher clinical and instrumental efficacy compared to the monotherapies, with comparable tolerability and safety profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dermatologic Clinic Policlinico Umberto 1, Sapienza University of Rome, Rome, Italy.
ORCID-Profile: Alfredo Rossi, Gemma Caro
Zitieren
APA
Rossi, A., & Caro, G. (2024). Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3‐arm, pilot trial. Journal of Cosmetic Dermatology, 23(2), 502-509. https://doi.org/10.1111/jocd.15953
Vancouver
Rossi A, Caro G. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3‐arm, pilot trial. Journal of Cosmetic Dermatology. 2024;23(2):502-509. doi:10.1111/jocd.15953
BibTeX
@article{Rossi2024,
author = {Rossi, Alfredo and Caro, Gemma},
title = {Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3‐arm, pilot trial},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
volume = {23},
number = {2},
pages = {502--509},
doi = {10.1111/jocd.15953}
}
EUVIMED